Privacy Law Library

Consumer Genetic Testing Providers

IN Consumer Genetic Testing

Genetic

Enacted by HEA 1521 (2025) and effective on passage, this chapter regulates direct-to-consumer genetic testing companies. Before testing, they must give a written privacy disclosure. They need separate, specific consent for extra testing, secondary uses, third-party access, retention beyond 30 days, and genetics-based marketing, and they may never give identifiable genetic data to insurers or employers.

Where
Indiana
Citation
Ind. Code ch. 24-4-24 (IC 24-4-24-1 to 24-4-24-11)
Status
In force
In force since
2025-05-06
Enforced by
Indiana Attorney General (exclusive authority, IC 24-4-24-11(a))
People can sue
No
Penalties
Injunction and a civil penalty of up to $7,500 per violation plus investigative costs and attorney's fees, after a 30-day written notice and cure opportunity (IC 24-4-24-11(b)-(e)).
Applies to
  • Consumer genetic testing providers: persons that, in the ordinary course of business and for consideration, offer direct-to-consumer genetic testing or collect, use, or analyze consumer-provided genetic data from such testing (IC 24-4-24-2)
  • Excludes testing ordered by a health care provider and subject to HIPAA, court-ordered testing, law enforcement testing, coroner testing, and research under the Common Rule or FDA human-subjects rules (IC 24-4-24-1(b))

What a privacy notice must say

  • Before testing, give the individual a written privacy policy disclosure covering collection, storage, security, retention, and use of samples and data, plus the identity of any third-party labs and recipients.IC 24-4-24-8

Rights it gives people

  • Give individuals access to their genetic data and a clear process to revoke consent; honor a revocation within 30 days, including destroying samples and data.IC 24-4-24-10(a)(2)-(4)

Practices it requires

  • Obtain freely given, specific, informed, and unambiguous consent, solicited separately for each action, before unrequested testing, other uses of the sample, third-party access to samples or identifiable data, retention beyond 30 days, or marketing based on results.IC 24-4-24-9(a)-(b)
  • Consent obtained through inaction, broad terms of service, hovering or closing content, or a manipulative interface (dark pattern) is invalid.IC 24-4-24-9(c)
  • Clearly label marketing sent because of the use of testing services, and make third-party marketers identify themselves.IC 24-4-24-10(a)(6)
  • Share samples or data with third parties only under contracts barring unconsented use, onward sharing, and over-retention.IC 24-4-24-10(a)(5)
  • Never provide non-deidentified genetic data to insurers, underwriting data suppliers, or the individual's employer, even with consent.IC 24-4-24-10(b)

Security duties

  • Implement commercially reasonable security measures for biological material and genetic testing data.IC 24-4-24-10(a)(1)

Sources

Checked against these sources on 2026-09-25 by research agent (Claude), primary sources.

Unverified: The effective date assumes 'effective upon passage' means the Governor's signature date (May 6, 2025), per the bill actions.

Research reference, not legal advice.